Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

DCSPKA..This is why we think Radient will merge with Provista Diagnostics..We like the word COMPANION and ASSOCIATED you understand..

http://provistadx.com/provistaDx-LabServices.html

Provista Companion Diagnostics (ProvistaCDx) provides comprehensive solutions for the molecular diagnostic and pharmaceutical industries. With significant expertise in clinical assay development and knowledge of most modern technologies for use across multiple disease states, ProvistaCDx offers:

Deep oncology domain expertise
Development and commercialization of diagnostics targeting women’s cancerss
Contract lab services utilizing state-of-the-art CLIA-certified, CAP-pending, GLP compliant laboratory
End-to-end support for projects from design to commercial execution
Highly experienced team
Experience partnering with pharmaceutical, biotechnology and diagnostic companies.

http://portal.uspto.gov/pair/PublicPair

12/414,518 DETECTION OF FIBRIN AND FIBRINOGEN DEGRADATION PRODUCTS AND ASSOCIATED METHODS OF PRODUCTION AND USE FOR THE DETECTION AND MONITORING OF CANCER